Word

ID ORIGINS

Status

Dead

Status Code

606

Status Date

Monday, July 17, 2017

Serial Number

86929082

Mark Type

4000

Filing Date

Friday, March 4, 2016

Published for Opposition

Tuesday, October 18, 2016

Abandoned Date

Monday, July 17, 2017

Trademark Owner History

The Translational Genomics Research Institute - Owner At Publication

Classifications

1 Diagnostic reagents for laboratory use, namely, for clinical, medical, or epidemiological laboratory use; chemical preparations for scientific purposes; reagents for use in scientific apparatus for chemical or biological analysis; testing kits containing reagents used in analyzing and detecting certain microorganisms for clinical, medical, or epidemiological laboratory use; microbiological genetic identity tests comprised of reagents for scientific research; biomedical compounds, namely, substrates used in analyzing and detecting certain nucleic acids for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use in science, namely, for clinical, medical, or epidemiological laboratory use

5 Medical diagnostic reagents for the analysis of body fluids; microbiological genetic identity tests for medical purposes comprised of reagents; diagnostic preparations for laboratory use, namely, for medical use; clinical medical reagents; diagnostic kits for medical use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids or microbiological specimens; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids or microbiological specimens; medical diagnostic test kits comprised of reagents and assays for testing of body fluids or microbiological specimens

9 Computer software for healthcare monitoring, namely, monitoring healthcare-acquired infections or community-acquired infections; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between testing facilities and health care professionals; mobile electronic devices, namely, personal digital assistants, tablet computers, mobile phones, laptop computers, and smartphones; laboratory apparatus, for use in medical laboratories, for analysis of body fluids and tissue

36 Consulting services in the field of insurance reimbursement; consulting services in the nature of providing information about insurance reimbursement

41 Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical conditions, including healthcare-acquired infections or community-acquired infections; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and insurance field; educational services, namely seminars and educational conventions

42 Medical and scientific research in the field of microbiological testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of microbiological-caused human disease; Scientific research consulting in the field of microbiological-based genetics, genomics, DNA sequencing, and bioinformatics; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for scientific research purposes; Genomic testing for scientific research purposes; Medical and scientific research, development and consulting in the field of infectious diseases; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and next generation sequencing; Medical and scientific research in the field of infectious disease diagnosis epidemiology; Data collection for research purposes, namely, the collection, testing and research of patient specimen molecular and/or genomic data; compiling genomic data for research purposes in the field of medical science; DNA-sequencing for scientific research purposes; Genotyping; Gene screening; consulting services in the field of microbiology; Medical and scientific research services in the field of health care; Scientific research consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; biological research; biomedical research; laboratory research in the field of microbiology, biochemistry, biology, health and medicine; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, namely, disease biology; scientific laboratory services; Software as a Service (SaaS) for medical and disease analysis

44 Medical testing for diagnostic or treatment purposes in the field of infectious diseases; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services, namely for evaluation of presence of infectious diseases; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing, namely determination of antibiotic resistance of microorganisms; Collection and preservation of DNA for medical and research purposes; Consulting services in the nature of providing medical information; Consulting services in the field of healthcare, insurance reimbursement, and microbiology; Genetic testing for scientific diagnostic purposes; Genomic testing for scientific diagnostic purposes; Genotype-based testing for medical purposes; Providing information in the field of infectious disease prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Microbiological screening for medical diagnostic purposes; Medical care consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; Consulting services in the nature of providing information about medical services

"ID"

Trademark Events

Jul 17, 2017

Abandonment Notice Mailed - No Use Statement Filed

Jul 17, 2017

Abandonment - No Use Statement Filed

Dec 13, 2016

Noa E-Mailed - Sou Required From Applicant

Oct 18, 2016

Official Gazette Publication Confirmation E-Mailed

Oct 18, 2016

Published For Opposition

Sep 28, 2016

Notification Of Notice Of Publication E-Mailed

Sep 5, 2016

Approved For Pub - Principal Register

Aug 12, 2016

Teas/Email Correspondence Entered

Aug 12, 2016

Correspondence Received In Law Office

Aug 12, 2016

Teas Response To Office Action Received

Apr 1, 2016

Notification Of Non-Final Action E-Mailed

Apr 1, 2016

Non-Final Action E-Mailed

Apr 1, 2016

Non-Final Action Written

Mar 27, 2016

Assigned To Examiner

Mar 10, 2016

New Application Office Supplied Data Entered In Tram

Mar 8, 2016

New Application Entered In Tram